Summary
To investigate the effect of omeprazole on serum and urinary pepsinogens and on gastric pepsin, 8 healthy male volunteers were studied before and after 9 days of treatment with omeprazole 60 mg/day p.o. Fasting serum samples and 24 h urine specimens were obtained, and gastric contents were aspirated at 15-min intervals, 4 prior to and 6 during pentagastrin 1.5 µg·kg−1·h−1 i.v. during intra-gastric perfusion with NaCl 0.9% and phenol red 3 mg·ml−1 as an inert recovery marker.
Basal and pentagastrin-stimulated volume and acid secretion were significantly decreased. The basal and pentagastrin stimulated pepsin output remained unchanged but pepsin concentration in gastric secretion was increased. Administration of omeprazole resulted in a significant increase in the serum PGA and PGC levels. The 24-h urinary excretion of PGA increased, but that of PGC remained unchanged, and so did the renal clearances of creatinine and pepsinogen A. The renal clearance of pepsinogen C decreased.
It was concluded that omeprazole did not affect gastric pepsin output, but, due to the decreased volume output, the concentration of pepsin in the gastric secretion was increased. Omeprazole increased the serum levels of pepsinogen A and C because more pepsinogen was released into the systemic circulation. This might be due to greater back-diffusion of pepsinogen from the gastric mucosa into the systemic circulation as a result of the higher pepsinogen concentration in gastric secretion.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Samloff IM (1969) Slow moving protease and the seven pepsinogens. Electrophoretic demonstration of the existence of eight proteolytic fractions in human gastric mucosa. Gastroenterology 57: 659–669
Eriksson AW, Foltmann B, Frants RR, Gedde-Dahl T Jr, Samloff IM, Taggart RTh (1985) Nomenclature committee report. In: Kreuning J, Samloff IM, Rotter JI, Eriksson AW (eds) Pepsinogens in man: Clinical and genetic advances. Alan R. Liss, New York
Foltmann B (1985) Purification, structure and activation of pepsinogens. In: Kreuning J, Samloff IM, Rotter JI, Eriksson AW (eds) Pepsinogens in man: Clinical and genetic advances. Alan R. Liss, New York
Samloff IM (1982) Pepsinogens I and II: Purification from gastric mucosa and radioimmunoassay in serum. Gastroenterology 82: 26–33
Hirschowitz BI (1967) Secretion of pepsinogens. In: Handbook of physiology: Alimentary canal. American Physiological Society, Washington DC
Samloff IM, Townes PL (1970) Electrophoretic heterogeneity and relationships of pepsinogens in human urine, serum and gastric mucosa. Gastroenterology 58: 462–469
ten Kate RW, Pals G, Donker AJM, Eriksson AW, Meuwissen SGM (1986) Renal clearance of pepsinogen A (PGA) in healthy volunteers [Abstract]. Gastroenterology 90: 1660
Lindt T, Cederberg C, Ekenved G, Haglund U, Olbe L (1983) Effect of omeprazole, a gastric proton pump inhibitor on pentagastrin stimulated acid secretion in man. Gut 24: 270–276
Clissold SP, Campoli-Richards DM (1986) Omeprazole, a preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome. Drugs 32: 14–47
Klinkenberg-Knol EC, Jansen JMBJ, Festen HPM, Meuwissen SGM, Lamers CBHW (1987) Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux esophagitis. Lancet 1: 349–351
Tytgat GNJ, Lamers CBHW, Hameeteman W, Jansen JMBJ, Wilson JA (1987) Omeprazole in peptic ulcers resistant to histamine H2-receptor antagonists. Aliment Pharmacol Ther 1: 31–39
Festen HPM, Thijs JC, Lamers CHBW, Jansen JMBJ, Pals G, Frants RR, Défize J, Meuwissen SGM (1984) Effect of oral omeprazole on serum gastrin and serum pepsinogen I levels. Gastroenterology 85: 1030–1034
Festen HPM, Tuynman HARE, Défize J, Pals G, Frants RR, Straub JP, Meuwissen SGM (1986) Effect of a single and repeated dose of oral omeprazole on gastric acid secretion and fasting serum gastrin and serum pepsinogen I levels. Dig Dis Sci 31: 561–566
Berstad A (1970) A modified hemoglobin substrate method for the estimation of pepsin in gastric juice. Scand J Gastroenterol 5: 343–348
Pals G, Räsänen V, Meuwissen SGM, Frants RR, Kostense PJ, Eriksson AW (1987) Enzyme-linked immunosorbent assay and radioimmunoassay of serum pepsinogen A. Scand J Clin Lab Invest 47: 29–33
Pals G, Westerveld BD, Pronk JC, Frants RR, Défize J, Kostense PJ, Biemond I, Meuwissen SGM, Eriksson AW (1986) Enzyme linked immunosorbent assay of serum pepsinogens A and C in normal controls and patients with superficial or atrophic gastritis. In: Pals G, Westerveld BD (eds) Human pepsinogens: Genetic and clinical aspects. Faculty of Medicine, Ph. D. thesis, Free University of Amsterdam, Amsterdam
Kammeraat C (1978) Modification of the alkaline picrate assay for creatinine to prevent spuriously elevated values by ketoacids. Clin Chim Acta 84: 119–128
Hobsley M, Silen W (1969) Use of an inert maker (phenol red) to improve accuracy in gastric secretion studies. Gut 10: 787–795
Wilson JA, Boyd EJS, Wormsley KG (1983) Effect of intraduodenal omeprazole on gastric acid and pepsin secretion. Gut 24: 497–498
Kittang E, Aerdland E, Schjonsby H (1984) Effect of omeprazole on acid pepsin and intrinsic factor secretion in healthy subjects. Scand J Gastroenterol 19 [Suppl 98]: 2
Howden CW, Forrest JAH, Reid JC (1984) Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man. Gut 25: 707–710
Waldum HL, Jorde R, Gunnes P (1982) Renal excretion of and the effect of posture on serum group I pepsinogens. Scand J Gastroenterol 17: 253–255
Maack T, Johnson V, Kau ST, Figueiredo J, Sigulem D (1979) Renal filtration, transport and metabolism of low-molecular weight proteins: A review. Kidney Int 16: 251–270
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ten Kate, R.W., Tuynman, H.A.R.E., Festen, H.P.M. et al. Effect of high dose omeprazole on gastric pepsin secretion and serum pepsinogen levels in man. Eur J Clin Pharmacol 35, 173–176 (1988). https://doi.org/10.1007/BF00609248
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00609248